ChADs 2 score has a better predictive value than ChA 2 Ds 2-VAsc score in elderly patients with atrial fibrillation
暂无分享,去创建一个
Q. Ma | Yun-li Xing | Ying Sun | Dai Zhang | Cuiying Wang | Xiaoying Ma
[1] H. Tomita,et al. Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[2] K. Hong,et al. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation. , 2015, Texas Heart Institute journal.
[3] L. Friberg,et al. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. , 2015, Journal of the American College of Cardiology.
[4] G. Lip,et al. Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. , 2014, QJM : monthly journal of the Association of Physicians.
[5] J. Healey,et al. 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. , 2014, The Canadian journal of cardiology.
[6] D. Lane,et al. The impact of atherosclerotic vascular disease in predicting a stroke, thromboembolism and mortality in atrial fibrillation patients: a systematic review , 2013, Journal of thrombosis and haemostasis : JTH.
[7] Jeroen J. Bax,et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. , 2012, European heart journal.
[8] J. Mant,et al. Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database (GPRD) 2000–2009 , 2012, Heart.
[9] Shih-AnnChen,et al. Atrial Fibrillation and the Risk of Ischemic Stroke , 2012 .
[10] T. Chao,et al. Atrial Fibrillation and the Risk of Ischemic Stroke: Does It Still Matter in Patients With a CHA2DS2-VASc Score of 0 or 1? , 2012, Stroke.
[11] J. Olesen,et al. Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study , 2012, Journal of thrombosis and haemostasis : JTH.
[12] G. Lip,et al. Reliable Identification of “Truly Low” Thromboembolic Risk in Patients Initially Diagnosed With “Lone” Atrial Fibrillation: The Belgrade Atrial Fibrillation Study , 2012, Circulation. Arrhythmia and electrophysiology.
[13] T. Chao,et al. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. , 2011, Journal of the American College of Cardiology.
[14] Lian-Yu Lin,et al. Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation-- a nation wide database analysis. , 2011, Atherosclerosis.
[15] J. Tolstrup,et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study , 2011, BMJ : British Medical Journal.
[16] A. Iorio,et al. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. , 2010, European journal of internal medicine.
[17] G. Lip,et al. Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort , 2010, Stroke.
[18] Gregory Y H Lip,et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.
[19] J. Beijnen,et al. Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial Fibrillation , 2010, Drugs & aging.
[20] Deepak L. Bhatt,et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. , 2008, American heart journal.
[21] D. Hu,et al. An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland China , 2008, Journal of epidemiology.
[22] A. Waldo. Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: A Report From the Euro Heart Survey on Atrial Fibrillation , 2008 .
[23] D. Singer,et al. Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study , 2005, Circulation.
[24] G. Lip,et al. Comparison of outcomes of patients with symptomatic peripheral artery disease with and without atrial fibrillation (the West Birmingham Atrial Fibrillation Project). , 2004, The American journal of cardiology.
[25] J. Halperin,et al. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. , 1999, Stroke.
[26] J. Halperin,et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. , 1998, Journal of the American College of Cardiology.
[27] W. Manning,et al. Transesophageal Echocardiography and Atrial Fibrillation: Added Value or Expensive Toy? , 1998, Annals of Internal Medicine.
[28] R B D'Agostino,et al. Stroke severity in atrial fibrillation. The Framingham Study. , 1996, Stroke.